You just read:

Intellect Neurosciences Responds to Official Action by United States Patent and Trademark Office in Relation to its ANTISENILIN® Alzheimer's Patent Application

News provided by

Intellect Neurosciences, Inc.

Nov 03, 2011, 09:35 ET